These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15531553)

  • 1. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.
    Velaga MR; Wilson V; Jennings CE; Owen CJ; Herington S; Donaldson PT; Ball SG; James RA; Quinton R; Perros P; Pearce SH
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5862-5. PubMed ID: 15531553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese.
    Ban Y; Tozaki T; Taniyama M; Tomita M; Ban Y
    Thyroid; 2005 Oct; 15(10):1115-8. PubMed ID: 16279843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease.
    Jennings CE; Owen CJ; Wilson V; Pearce SH
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):362-5. PubMed ID: 15730420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population.
    Jennings CE; Owen CJ; Wilson V; Pearce SH
    J Mol Endocrinol; 2005 Jun; 34(3):859-63. PubMed ID: 15956353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo.
    Cantón I; Akhtar S; Gavalas NG; Gawkrodger DJ; Blomhoff A; Watson PF; Weetman AP; Kemp EH
    Genes Immun; 2005 Oct; 6(7):584-7. PubMed ID: 16015369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene R620W variant and sporadic idiopathic hypoparathyroidism in Asian Indians.
    Ray D; Tomar N; Gupta N; Goswami R
    Int J Immunogenet; 2006 Aug; 33(4):237-40. PubMed ID: 16893384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.
    Bottini N; Musumeci L; Alonso A; Rahmouni S; Nika K; Rostamkhani M; MacMurray J; Meloni GF; Lucarelli P; Pellecchia M; Eisenbarth GS; Comings D; Mustelin T
    Nat Genet; 2004 Apr; 36(4):337-8. PubMed ID: 15004560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease.
    Roycroft M; Fichna M; McDonald D; Owen K; Zurawek M; Gryczyńska M; Januszkiewicz-Lewandowska D; Fichna P; Cordell H; Donaldson P; Nowak J; Pearce S
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):358-62. PubMed ID: 18710467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.
    Donner H; Braun J; Seidl C; Rau H; Finke R; Ventz M; Walfish PG; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4130-2. PubMed ID: 9398726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
    van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
    Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility.
    Sutherland A; Davies J; Owen CJ; Vaikkakara S; Walker C; Cheetham TD; James RA; Perros P; Donaldson PT; Cordell HJ; Quinton R; Pearce SH
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3338-41. PubMed ID: 17535987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase PTPN22 in human autoimmunity.
    Vang T; Miletic AV; Bottini N; Mustelin T
    Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2007 Aug; 8():54. PubMed ID: 17697317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease.
    Cuddihy RM; Schaid DS; Bahn RS
    Thyroid; 1996 Aug; 6(4):261-5. PubMed ID: 8875744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1.
    Reddy MV; Johansson M; Sturfelt G; Jönsen A; Gunnarsson I; Svenungsson E; Rantapää-Dahlqvist S; Alarcón-Riquelme ME
    Genes Immun; 2005 Dec; 6(8):658-62. PubMed ID: 16052172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
    Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population.
    Kahles H; Ramos-Lopez E; Lange B; Zwermann O; Reincke M; Badenhoop K
    Eur J Endocrinol; 2005 Dec; 153(6):895-9. PubMed ID: 16322396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
    Zeitlin AA; Heward JM; Brand OJ; Newby PR; Franklyn JA; Gough SC; Simmonds MJ
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):380-4. PubMed ID: 16918960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of PTPN22 haplotypes with Graves' disease.
    Heward JM; Brand OJ; Barrett JC; Carr-Smith JD; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 2007 Feb; 92(2):685-90. PubMed ID: 17148556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.